Description

Book Synopsis

Strategize, plan, and execute comprehensive drug-drug interaction assessments for therapeutic biologics

Offering both theory and practical guidance, this book fully explores drug-drug interaction assessments for therapeutic biologics during the drug development process. It draws together and analyzes all the latest findings and practices in order to present our current understanding of the topic and point the way to new research. Case studies and examples, coupled with expert advice, enable readers to better understand the complex mechanisms of biologic drug-drug interactions.

Drug-Drug Interactions for Therapeutic Biologics features contributions from leading international experts in all areas of therapeutic biologics drug development and drug-drug interactions. The authors'' contributions reflect a thorough review and analysis of the literature as well as their own firsthand laboratory experience. Coverage includes such essential topics as:


  • Table of Contents

    PREFACE ix

    ABOUT THE EDITORS xi

    CONTRIBUTORS xiii

    1. DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS: A JOURNEY JUST BEGINNING 1
    Honghui Zhou and Bernd Meibohm

    2. PHARMACOKINETIC AND PHARMACODYNAMIC-BASED DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 5
    Dan Lu, Sandhya Girish, Frank-Peter Theil, and Amita Joshi

    3. DRUG INTERACTION ASSESSMENT STRATEGIES: SMALL MOLECULES VERSUS THERAPEUTIC PROTEINS 39
    Shannon Dallas, Carlo Sensenhauser, Souvik Chattopadhyay, and Jose Silva

    4. MODEL-INDEPENDENT AND MODEL-BASED METHODS TO ASSESS DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 63
    Di Wu and Jeffrey S. Barrett

    5. UTILITY OF IN VITRO METHODS IN DRUG–DRUG INTERACTION ASSESSMENT AND PREDICTION FOR THERAPEUTIC BIOLOGICS 73
    Theresa Nguyen, Narendra Kishnani, and Raymond Evers

    6. USE OF ANIMAL MODELS FOR PROJECTION OF CLINICAL DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 103
    Eugenia Kraynov and Martin E. Dowty

    7. THE COCKTAIL APPROACH AND ITS UTILITY IN DRUG–DRUG INTERACTION ASSESSMENTS FOR THERAPEUTIC PROTEINS 111
    Alexander Jetter and Uwe Fuhr

    8. LOGISTIC CONSIDERATIONS IN STUDY DESIGN FOR BIOLOGIC DRUG–DRUG INTERACTION ASSESSMENTS 119
    Min Zhu and Yu-Nien (Tom) Sun

    9. STATISTICAL CONSIDERATIONS IN ASSESSING DRUG–DRUG INTERACTIONS FOR THERAPEUTIC BIOLOGICS 139
    Chuanpu Hu and Honghui Zhou

    10. SCIENTIFIC PERSPECTIVES ON THERAPEUTIC PROTEIN DRUG–DRUG INTERACTION ASSESSMENTS 155
    Hong Zhao, Lei Zhang, Kellie Reynolds, and Shiew-Mei Huang

    11. DISEASE–DRUG–DRUG INTERACTION ASSESSMENTS FOR TOCILIZUMAB—A MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR TO TREAT PATIENTS WITH RHEUMATOID ARTHRITIS 191
    Xiaoping Zhang and Barbara J. Brennan

    12. DRUG–DRUG INTERACTIONS FOR ETANERCEPT—A FUSION PROTEIN 207
    Joan Korth-Bradley

    13. DRUG INTERACTIONS OF CYTOKINES AND ANTICYTOKINE THERAPEUTIC PROTEINS 215
    J. Greg Slatter, Larry C. Wienkers, and Leslie J. Dickmann

    14. DRUG INTERACTIONS FOR GROWTH FACTORS AND HORMONES 239
    Yow-Ming C. Wang and Tarundeep Kakkar

    15. DRUG–DRUG INTERACTIONS FOR NUCLEIC ACID-BASED DERIVATIVES 257
    Jian Wang and Hong Zhao

    APPENDIX: MONOGRAPHS FOR DRUG-DRUG INTERACTIONS OF THERAPEUTICS BIOLOGICS 275
    Jocelyn Leu, Simone Kasek, Christine Li, Wararat Limothai, Dora Babu Madhura, Chetan Rathi, Sumit Rawal, Josiah Ryman, Margaret Thomson, Ashit Trivedi, Honghui Zhou, and Bernd Meibohm

    INDEX 351

DrugDrug Interactions for Therapeutic Biologics

    Product form

    £999.99

    Includes FREE delivery

    A Hardback by Honghui Zhou, Bernd Meibohm

    Out of stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of DrugDrug Interactions for Therapeutic Biologics by Honghui Zhou

      Publisher: John Wiley & Sons Inc
      Publication Date: 13/08/2013
      ISBN13: 9781118032169, 978-1118032169
      ISBN10: 1118032160

      Description

      Book Synopsis

      Strategize, plan, and execute comprehensive drug-drug interaction assessments for therapeutic biologics

      Offering both theory and practical guidance, this book fully explores drug-drug interaction assessments for therapeutic biologics during the drug development process. It draws together and analyzes all the latest findings and practices in order to present our current understanding of the topic and point the way to new research. Case studies and examples, coupled with expert advice, enable readers to better understand the complex mechanisms of biologic drug-drug interactions.

      Drug-Drug Interactions for Therapeutic Biologics features contributions from leading international experts in all areas of therapeutic biologics drug development and drug-drug interactions. The authors'' contributions reflect a thorough review and analysis of the literature as well as their own firsthand laboratory experience. Coverage includes such essential topics as:


      • Table of Contents

        PREFACE ix

        ABOUT THE EDITORS xi

        CONTRIBUTORS xiii

        1. DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS: A JOURNEY JUST BEGINNING 1
        Honghui Zhou and Bernd Meibohm

        2. PHARMACOKINETIC AND PHARMACODYNAMIC-BASED DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 5
        Dan Lu, Sandhya Girish, Frank-Peter Theil, and Amita Joshi

        3. DRUG INTERACTION ASSESSMENT STRATEGIES: SMALL MOLECULES VERSUS THERAPEUTIC PROTEINS 39
        Shannon Dallas, Carlo Sensenhauser, Souvik Chattopadhyay, and Jose Silva

        4. MODEL-INDEPENDENT AND MODEL-BASED METHODS TO ASSESS DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 63
        Di Wu and Jeffrey S. Barrett

        5. UTILITY OF IN VITRO METHODS IN DRUG–DRUG INTERACTION ASSESSMENT AND PREDICTION FOR THERAPEUTIC BIOLOGICS 73
        Theresa Nguyen, Narendra Kishnani, and Raymond Evers

        6. USE OF ANIMAL MODELS FOR PROJECTION OF CLINICAL DRUG–DRUG INTERACTIONS FOR THERAPEUTIC PROTEINS 103
        Eugenia Kraynov and Martin E. Dowty

        7. THE COCKTAIL APPROACH AND ITS UTILITY IN DRUG–DRUG INTERACTION ASSESSMENTS FOR THERAPEUTIC PROTEINS 111
        Alexander Jetter and Uwe Fuhr

        8. LOGISTIC CONSIDERATIONS IN STUDY DESIGN FOR BIOLOGIC DRUG–DRUG INTERACTION ASSESSMENTS 119
        Min Zhu and Yu-Nien (Tom) Sun

        9. STATISTICAL CONSIDERATIONS IN ASSESSING DRUG–DRUG INTERACTIONS FOR THERAPEUTIC BIOLOGICS 139
        Chuanpu Hu and Honghui Zhou

        10. SCIENTIFIC PERSPECTIVES ON THERAPEUTIC PROTEIN DRUG–DRUG INTERACTION ASSESSMENTS 155
        Hong Zhao, Lei Zhang, Kellie Reynolds, and Shiew-Mei Huang

        11. DISEASE–DRUG–DRUG INTERACTION ASSESSMENTS FOR TOCILIZUMAB—A MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-6 RECEPTOR TO TREAT PATIENTS WITH RHEUMATOID ARTHRITIS 191
        Xiaoping Zhang and Barbara J. Brennan

        12. DRUG–DRUG INTERACTIONS FOR ETANERCEPT—A FUSION PROTEIN 207
        Joan Korth-Bradley

        13. DRUG INTERACTIONS OF CYTOKINES AND ANTICYTOKINE THERAPEUTIC PROTEINS 215
        J. Greg Slatter, Larry C. Wienkers, and Leslie J. Dickmann

        14. DRUG INTERACTIONS FOR GROWTH FACTORS AND HORMONES 239
        Yow-Ming C. Wang and Tarundeep Kakkar

        15. DRUG–DRUG INTERACTIONS FOR NUCLEIC ACID-BASED DERIVATIVES 257
        Jian Wang and Hong Zhao

        APPENDIX: MONOGRAPHS FOR DRUG-DRUG INTERACTIONS OF THERAPEUTICS BIOLOGICS 275
        Jocelyn Leu, Simone Kasek, Christine Li, Wararat Limothai, Dora Babu Madhura, Chetan Rathi, Sumit Rawal, Josiah Ryman, Margaret Thomson, Ashit Trivedi, Honghui Zhou, and Bernd Meibohm

        INDEX 351

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account